News

2021
3 May

Response to the Revision of the EU General Pharmaceuticals Legislation
3 May

HAI Statement on The Oslo Medicines Initiative at the WHO Virtual Consultation with Non-State Actors, 31 March 2021
1 March

Response to EU’s HERA Initiative Consultation
10 February

Transparency, Accountability and Access to Medicines: European Projects 2021
8 February

How the Netherlands and other EU Governments Respond to the Challenge of Sustainable Access to Medicines
22 January

Statement to EB148 on WHO reform: involvement of non-State actors in WHO’s governing bodies
21 January

Letter to Dr Tedros: Leadership and Advocacy for C-TAP
21 January

Statement to EB148 on expanding access to effective treatments for cancer and rare and orphan diseases, including medicines, vaccines, medical devices
19 January

Statement to EB148 on the COVID-19 response
18 January

Statement to EB148 on global strategy and plan of action on public health, innovation and intellectual property
11 January

Access to Internationally Controlled Essential Medicines in sub-Saharan Africa
2020
18 December

Joint HTA Assessment in Europe: Progress in 2020
14 December

Cross-country Cooperation Schemes: A fair-weather solution to the issue of access to medicines in Europe?
14 October

FACT SHEET: Impact and Knowledge of COVID-19 and related measures in rural Kenyan households
8 October

Making Medicines Authorisation Procedures Work for Patients
19 August

Clinical Trial Transparency in the Netherlands: Mapping Unreported Drug Trials
31 July

European Commission Intellectual Property Action Plan
17 July

Partners for Change
12 June

SRHC: Availability, Affordability and Stock-outs – Uganda 2019
11 June

Driving Change in Access to Medicines – Annual Report 2019
4 June

COVID-19 Technology Access Pool
28 May

SRHC: Availability, Affordability and Stockouts – Zambia 2019
26 May

Letter to Dr Tedros: The Challenge of Access to Insulin Amidst COVID-19
20 May

Results from the HSA Partnership’s Learning Agenda
25 March

The fight against COVID-19: let’s make public investments count for people
8 March

SRHC: Availability, Affordability and Stockouts- Kenya 2019
13 February

EU Priorities 2020-2024: Medicines policy that works for people
11 February

Patient-centred Advocacy: HAI’s Work in Europe 2020
8 February

Statement to EB146 on non-State actors on official relations with WHO
7 February

Statement to EB146 on Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property